Janse MJ - Search Results

1

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.

Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P. Julian DG, et al. Among authors: janse mj. Lancet. 1997 Mar 8;349(9053):667-74. doi: 10.1016/s0140-6736(96)09145-3. Lancet. 1997. PMID: 9078197 Clinical Trial.

2

Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction? The European Myocardial Infarct Amiodarone Trial (EMIAT).

Schwartz PJ, Camm AJ, Frangin G, Janse MJ, Julian DG, Simon P. Schwartz PJ, et al. Among authors: janse mj. Eur Heart J. 1994 May;15(5):620-4. doi: 10.1093/oxfordjournals.eurheartj.a060557. Eur Heart J. 1994. PMID: 8056000 Clinical Trial. No abstract available.

3

Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial).

Janse MJ, Malik M, Camm AJ, Julian DG, Frangin GA, Schwartz PJ. Janse MJ, et al. Eur Heart J. 1998 Jan;19(1):85-95. doi: 10.1053/euhj.1997.0823. Eur Heart J. 1998. PMID: 9503180

4

Congenital and acquired long QT syndrome.

Camm AJ, Janse MJ, Roden DM, Rosen MR, Cinca J, Cobbe SM. Camm AJ, et al. Among authors: janse mj. Eur Heart J. 2000 Aug;21(15):1232-7. doi: 10.1053/euhj.2000.2222. Eur Heart J. 2000. PMID: 10924312 Review. No abstract available.

5

The works of Dirk Durrer (1918-1984).

Opthof T, Janse MJ, Kléber AG, Wellens HJ, Wilde AA, Coronel R. Opthof T, et al. Among authors: janse mj. Neth Heart J. 2012 Oct;20(10):430-3. doi: 10.1007/s12471-012-0313-7. Neth Heart J. 2012. PMID: 22875727 Free PMC article. No abstract available.

6

Electrophysiology of the A-V node in relation to A-V nodal reentry.

Janse MJ, McGuire MA, Loh P, Thibault B, Hocini M, de Bakker JM. Janse MJ, et al. Jpn Heart J. 1996 Sep;37(5):785-91. doi: 10.1536/ihj.37.785. Jpn Heart J. 1996. PMID: 8973390 Review.

7

The role of basic arrhythmia research. The continued need for experiments in the intact heart and organism.

Allessie A, Avkiran M, Borggrefe M, Carmeliet E, Cobbe SM, Dhein S, Haverkamp W, Hindricks G, Janse MJ, Kléber AG, et al. Allessie A, et al. Among authors: janse mj. Eur Heart J. 1995 Nov;16(11):1469-75. Eur Heart J. 1995. PMID: 8881837 Review. No abstract available.

8

Sudden death during longterm ambulatory monitoring.

Roelandt J, Klootwijk P, Lubsen J, Janse MJ. Roelandt J, et al. Among authors: janse mj. Eur Heart J. 1984 Jan;5(1):7-20. doi: 10.1093/oxfordjournals.eurheartj.a061555. Eur Heart J. 1984. PMID: 6705808

9

Chaos in the prediction of sudden death.

Janse MJ. Janse MJ. Eur Heart J. 1995 Mar;16(3):299-301. doi: 10.1093/oxfordjournals.eurheartj.a060910. Eur Heart J. 1995. PMID: 7789370 No abstract available.

10

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology.

Haverkamp W, Breithardt G, Camm AJ, Janse MJ, Rosen MR, Antzelevitch C, Escande D, Franz M, Malik M, Moss A, Shah R. Haverkamp W, et al. Among authors: janse mj. Eur Heart J. 2000 Aug;21(15):1216-31. doi: 10.1053/euhj.2000.2249. Eur Heart J. 2000. PMID: 10924311 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results